4.6 Article

Ganglioglioma with adverse clinical outcome and atypical histopathological features were defined by alterations in PTPN11/KRAS/NF1 and other RAS-/MAP-Kinase pathway genes

Related references

Note: Only part of the references are listed.
Article Clinical Neurology

The genomic landscape across 474 surgically accessible epileptogenic human brain lesions

Javier A. Lopez-Rivera et al.

Summary: Lopez-Rivera et al. conducted a study on the genetic architecture of different types of epileptic brain lesions. They discovered novel somatic chromosomal alterations, identified new genes and genotype-phenotype associations, and supported the role of genetics in the histopathological diagnosis of epileptic lesions. The findings provide valuable insights for improving treatment of drug-resistant focal epilepsy.

BRAIN (2023)

Article Oncology

Heterogeneity and excitability of BRAFV600E-induced tumors is determined by Akt/mTOR-signaling state and Trp53-loss

Silvia Cases-Cunillera et al.

Summary: mTOR signaling and Trp53 loss are critical factors determining the biological diversity and electrical activity of BRAF(V600E)-induced tumors.

NEURO-ONCOLOGY (2022)

Article Clinical Neurology

Integrated genotype-phenotype analysis of long-term epilepsy-associated ganglioglioma

Yujiao Wang et al.

Summary: This study investigated the genetic landscape and genotype-phenotype correlation of ganglioglioma (GG) by analyzing 30 GG specimens, revealing that the majority of GG exhibit BRAF p.V600E mutations. Different histopathology patterns may correspond to different genetic alterations.

BRAIN PATHOLOGY (2022)

Review Chemistry, Medicinal

Crystallographic landscape of SHP2 provides molecular insights for SHP2 targeted drug discovery

Yihui Song et al.

Summary: This review provides an overview of the structural landscape of SHP2 under physiological and pathological conditions and comprehensively analyzes the binding models of SHP2/inhibitor complexes. The structural features of SHP2 under pathological conditions and co-crystal structures of SHP2/inhibitor complexes will facilitate the design of structure-guided SHP2 inhibitors. Additionally, proteolysis targeting chimeric (PROTAC) based SHP2 degraders show therapeutic promise for cancer therapy.

MEDICINAL RESEARCH REVIEWS (2022)

Article Biochemistry & Molecular Biology

Glioblastoma hijacks neuronal mechanisms for brain invasion

Varun Venkataramani et al.

Summary: A subpopulation of glioblastoma cells lacking connections with other tumor cells and astrocytes but receiving synaptic input from neurons drives whole-brain colonization. These cells resemble neuronal and neural-progenitor-like states and invade the brain using mechanisms similar to neuronal migration. Neuronal activity induces calcium signals, leading to the formation of tumor microtubes and increased invasion speed. This study reveals how neuronal mechanisms govern glioblastoma cell invasion and explains the close interlink between tumor dissemination and cellular heterogeneity.
Article Clinical Neurology

Detection of brain somatic variation in epilepsy-associated developmental lesions

Tracy A. Bedrosian et al.

Summary: This study identified somatic and germline variants associated with epilepsy in children, shedding light on the genetic basis of structural brain abnormalities leading to focal epilepsy and suggesting new candidate disease genes.

EPILEPSIA (2022)

Article Clinical Neurology

Targeted Next-Generation Sequencing Reveals Divergent Clonal Evolution in Components of Composite Pleomorphic Xanthoastrocytoma-Ganglioglioma

Calixto-Hope G. Lucas et al.

Summary: Composite pleomorphic xanthoastrocytoma-ganglioglioma (PXA-GG) is a rare central nervous system neoplasm consisting of two distinct but intermingled components. This study found that both the PXA and GG components of PXA-GG harbor BRAF p.V600E hotspot mutations, but the PXA components also exhibit CDKN2A homozygous deletion and more frequent copy number alterations.

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2022)

Review Clinical Neurology

Neocortical development and epilepsy: insights from focal cortical dysplasia and brain tumours

Ingmar Blumcke et al.

Summary: Significant progress has been made in understanding the genetic and morphogenic processes underlying cortical malformations and developmental brain tumors, highlighting the potential for disease caused by somatic variants and the possibility of gene therapy. The timing of genetic events and specific genes during neurodevelopment determine the nature and size of lesions.

LANCET NEUROLOGY (2021)

Article Multidisciplinary Sciences

Long-term epilepsy-associated tumors: transcriptional signatures reflect clinical course

Daniel Delev et al.

SCIENTIFIC REPORTS (2020)

Review Neurosciences

Low-grade developmental and epilepsy associated brain tumors: a critical update 2020

Rutger Juriaan Slegers et al.

ACTA NEUROPATHOLOGICA COMMUNICATIONS (2020)

Review Medicine, General & Internal

Low-Grade Gliomas in Patients with Noonan Syndrome: Case-Based Review of the Literature

Mariachiara Lodi et al.

DIAGNOSTICS (2020)

Article Multidisciplinary Sciences

Glutamatergic synaptic input to glioma cells drives brain tumour progression

Varun Venkataramani et al.

NATURE (2019)

Article Multidisciplinary Sciences

DNA methylation-based classification of central nervous system tumours

David Capper et al.

NATURE (2018)

Article Biochemistry & Molecular Biology

BRAF somatic mutation contributes to intrinsic epileptogenicity in pediatric brain tumors

Hyun Yong Koh et al.

NATURE MEDICINE (2018)

Article Biochemical Research Methods

Preprocessing, normalization and integration of the Illumina HumanMethylationEPIC array with minfi

Jean-Philippe Fortin et al.

BIOINFORMATICS (2017)

Article Medicine, General & Internal

Histopathological Findings in Brain Tissue Obtained during Epilepsy Surgery

I. Blumcke et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Article Genetics & Heredity

Noonan Syndrome, PTPN11 Mutations, and Brain Tumors. A Clinical Report and Review of the Literature

Aurore Siegfried et al.

AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2017)

Article Clinical Neurology

Low-grade epilepsy-associated neuroepithelial tumours - the 2016 WHO classification

Ingmar Bluemcke et al.

NATURE REVIEWS NEUROLOGY (2016)

Article Multidisciplinary Sciences

Brain tumour cells interconnect to a functional and resistant network

Matthias Osswald et al.

NATURE (2015)

Article Medicine, General & Internal

Noonan syndrome

Amy E. Roberts et al.

LANCET (2013)

Article Genetics & Heredity

A framework for variation discovery and genotyping using next-generation DNA sequencing data

Mark A. DePristo et al.

NATURE GENETICS (2011)

Review Pediatrics

Noonan Syndrome: Clinical Features, Diagnosis, and Management Guidelines

Alicia A. Romano et al.

PEDIATRICS (2010)

Article Genetics & Heredity

Functional analysis of PTPN11/SHP-2 mutants identified in Noonan syndrome and childhood leukemia

T Niihori et al.

JOURNAL OF HUMAN GENETICS (2005)